Comparison of in vitro activities of antifungal drugs and propolis against yeasts isolated from patients with superficial mycoses

Annals of Microbiology

Volumn 57, Issue 2, 2007, Pages 269-272

  Sílící, Sibel ^a   KOc, Ayşe Nedret ^a   Mistik, Selcuk ^a  

^a ERCIYES UNIVERSITY   (Turkey)

Author keywords

Candida spp; Microdilution assay; Propolis; Superficial mycoses

Indexed keywords

CANDIDA; CANDIDA ALBICANS;

EID: 34547204513     PISSN: 15904261     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03175218     Document Type: Article

References (24)

1. Elder J.V., Joosten L., Verhaeghe A., Surmont I. (1996). Fluconazole and amphotericine B antifungal susceptibility testing by National Committee for Clinical Laboratory Standards broth macrodilution method compared with E test and semiautomated broth microdilution test. J. Clin. Microbiol., 32: 2099-2102.
2. Espinel-Ingroff A., Kerkering T.M., Goldson P.R., Shadomy S. (1991). Comparison study of broth macrodilution and broth microdilution antifungal susceptibility testing of yeast isolates. Diagn. Microbiol. Infect. Dis., 19: 9-13.
3. Fernandes Jr. A., Sugizaki M.F., Fago M.L., Funari S.R.C., Lopes C.A.M. (1995). In vitro activiy of propolis against bacterial and yeast pathogens isolated from human infections. J. Venom. Anim. Toxins, 1: 63-69.
4. Fernandez-Torres B., Vazquez-Veiga H., Llova X., Pereiro M., Guarro J. (2000). In vitro susceptibility to itraconazole, clotrimazole, ketoconazole, and terbinafine of 100 isolates of Trichophyton rubrum. Chemotherapy, 46: 390-394.
5. Ghisalberti E. (1979). Propolis: A review. Bee World, 60: 59-84.
6. Greenaway W., May J., Scaysbrook T., Whatley F.R. (1991). Identification by gas chromotography-mass spectrometry of 150 compounds In propolis. Z. Naturforsch., 46c: 11-12.
7. Haris R. (2002). Progress with superficial mycoses using essential oils. Int. J. Aromather., 12 (2): 83-91.
8. Holderna E., Kedzia B. (1987). Investigation upon the combined action of propolis and antymycotic drugs on Candida albicans. Herba Pol., 33: 145-151.
9. Jessup C.J., Warner J., Isham N., Hasan I., Ghannoum M.A. (2000). Antifungal susceptibility testing of dermatophytes: establishing a medium for inducing conidial growth and evaluation of susceptibility of clinical isolates. J. Clin. Microbiol., 38: 341-344.
10. Kartal M.S., Yildiz S., Kaya S., Kurucu S., Topçu G. (2003). Antimicrobial activity of propolis samples from two different regions of Anatolia. J. Ethnopharmacol., 2860: 1-5.
11. Keskin N., Hazir S., Baser K.H.C., Kürkçüoǧlu M. (2001). Antibacterial activity and chemical composition of Turkish propolis. Z. Naturforsch. C, 56: 1112-1115.
12. Koc A.N., Silici S., Ayangil D., Ferahbaş A., Çankaya S. (2005). Comparison of in vitro activities of antifungal drugs and ethanolic extract of propolis against Trichophyton rubrum and T. mentagrophytes by using a microdilution assay. Mycoses, 48: 205-210.
13. Kujumgiev A., Bankova V., Ignatova A., Popov S. (1993). Antibacterial activity of propolis, some of its components and their analogs. Pharmazie, 48: 785-786.
14. Kujumgiev A., Tsvetkova I., Serkedjieva Yu., Bankova V., Christov R., Popov S (1999). Antibacterial, antifungal and antiviral activity of propolis of different geographic origin. J. Ethnopharmacol., 64: 235-240.
15. Metzner J., Bekemeier H., Paintz M., Schneidewind E. (1979). Zur antimikrobiellen Wirksamkeit von propolis und propolisinhaltsstoffen. Pharmazie, 34: 97-102.
16. NCCLS - National Committee for Clinical Laboratory Standards (1995). Reference Method for Broth Dilution Antifungal Susceptibility Testing for Yeasts. Document M27-T., National Committee for Clinical Laboratory Standards, Villanova, PA.
17. Ota C., Unterkircher C., Fantinato V., Shimizu M.T. (2001). Antifungal activity of propolis on different species of Candida. Mycoses, 44: 375-378.
18. Park Y.K., Koo M.H., Abreu J.A.S., Ikegaki M., Cury J.A., Rosalen P.L. (1998). Antimicrobial activity of propolis on oral microorganisms. Curr. Microbiol., 36: 24-28.
19. Pfaller M.A., Rinaldi M.G., Galgiani J.N., Bartlett M.S., Body B.A., Espinel-Ingroff A., Fromtling R.A., Hall G.S., Hughes C.E., Odds F.C., Sugar A.M. (1990). Collaborative investigation of variables in susceptibility testing of yeasts. Antimicrob. Agents Chemoter., 34: 1648-1654.
20. Pepeljnjak S., Jalsenjak I., Maysinger D. (1985). Flavonoid content propolis extracts and growth inhibition of Bacillus subtilis. Pharmazie, 40: 122-123.
21. Popova M., Silici S., Kaftanoǧlu O., Bankova V. (2005). Antibacterial activity of Turkish propolis and its qualitative and quatitative chemical composition. Phytomedicine, 12: 221-228.
22. Silici S., Kaftanoglu O. (2003). Antimicrobial analysis of propolis samples from different regions in Turkey. Uludag Bee Journal, 3 (3): 16-18.
23. Velikova M., Bankova V., Sorkun K., Houcine S., Tsvetkova I., Kujumgiev A. (2000). Propolis from Mediterranean Region: Chemical composition and antimicrobial activity. Z. Naturforsch. C, 55: 790-793.
24. Waren N.G., Hazen N.C. (1995). Candida, Cryptococcus and other yeast of medical importance. In: Murray P.R., Baron E.J., Pfaller M.A., Tenover F.C., Yolken R.H., Eds, Manual of Clinical Microbiology, American Society for Microbiology, Washington DC, pp: 723-737.